Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11 years: Results from an active pharmacovigilance study in central Italy

This survey investigated on adverse events after vaccination with mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine in children aged 5–11 years in central Italy through active surveillance reporting. During December 2021–January 2022, parents of children who undergone vaccination were interviewed u...

Descripción completa

Detalles Bibliográficos
Autores principales: Ripabelli, Giancarlo, Sammarco, Michela Lucia, D’Amico, Antonio, De Dona, Roberta, Iafigliola, Mariagrazia, Parente, Albino, Samprati, Nicandro, Santagata, Arturo, Adesso, Carmen, Natale, Anna, Di Palma, Michela Anna, Cannizzaro, Fabio, Romano, Roberto, Licianci, Antonietta, Tamburro, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746364/
https://www.ncbi.nlm.nih.gov/pubmed/36315849
http://dx.doi.org/10.1080/21645515.2022.2126668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746364/
https://www.ncbi.nlm.nih.gov/pubmed/36315849
http://dx.doi.org/10.1080/21645515.2022.2126668

Ejemplares similares